V. Marco Ranieri et al, 10.1056/nejmoa1202290
Drotrecogin Alfa (Activated) in Adults with Septic Shock
Conclusion: DrotAA did not significantly reduce mortality at 28 or 90 days, as compared with placebo, in patients with septic shock.
Drotrecogin Alfa (Activated) in Adults with Septic Shock
Conclusion: DrotAA did not significantly reduce mortality at 28 or 90 days, as compared with placebo, in patients with septic shock.
